Betalin Therapeutics For Profit
Betalin is a company developing a micro-pancreas to help diabetic patients liberate from their daily insulin dependency. The company uses a combination of stem cell technology and tissue engineering to create a fully functional engineered micro-pancreas that can supply daily insulin replacement. The micro-pancreas responds to the patient's blood glucose levels by releasing regulated therapeutic levels of insulin. The company aims to provide a long-term solution for the management of diabetes. The company has a team of scientists, engineers, clinical experts, and an advisory board. Contact info: +972-2-992-2025, info@betalintherapeutics.com, Jerusalem Bio Park (JBP), Minrav Bldg, 1st Floor, Hadassah Ein Keren Campus, Jerusalem, Israel.
Founded Date:
2015-07-01
Headquarters:
Ramat Gan, Tel Aviv, Israel
Technology:
Stem cells
Employee Number:
1-10
Industry:
Regenerative Medicine
Estimated Revenue:
$1.4Mper year
Number Of Exists:
N/A
Funding Status:
Early Stage Venture
Investor Type:
N/A
Investment Stage:
N/A